Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 5,404 | 4,848 | 4,670 | 3,265 | 3,366 |
| Cost of Goods | N/A | N/A | N/A | N/A | 497 |
| Gross Profit | 5,404 | 4,848 | 4,670 | 3,265 | 2,869 |
| Operating Expenses | 14,720 | 11,460 | 9,723 | 10,595 | 7,673 |
| Operating Income | -9,316 | -6,612 | -5,053 | -7,330 | -4,307 |
| Interest Expense | 0 | 0 | 0 | 0 | 294 |
| Other Income | 95 | 404 | 658 | 1,192 | 843 |
| Pre-tax Income | -9,221 | -6,208 | -4,395 | -6,138 | -3,758 |
| Net Income Continuous | -9,221 | -6,208 | -4,395 | -6,138 | -3,758 |
| Net Income Discontinuous | N/A | 1,845 | 617 | 3,624 | 12,310 |
| Net Income | $-9,221 | $-4,363 | $-3,778 | $-2,514 | $8,552 |
| EPS Basic Total Ops | -32.00 | -16.80 | -15.20 | -9.60 | 33.60 |
| EPS Basic Continuous Ops | -32.00 | -24.00 | -17.60 | -24.00 | -15.20 |
| EPS Basic Discontinuous Ops | N/A | 7.18 | 2.42 | 14.30 | 48.80 |
| EPS Diluted Total Ops | -32.00 | -16.80 | -15.20 | -9.60 | 33.60 |
| EPS Diluted Continuous Ops | -32.00 | -24.00 | -17.60 | -24.00 | -15.20 |
| EPS Diluted Discontinuous Ops | N/A | 7.18 | 2.42 | 14.30 | 48.72 |
| EBITDA(a) | $-8,686 | $-5,959 | $-4,582 | $-6,769 | $-4,034 |